These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35529445)

  • 21. Identification of average molecular weight (AMW) as a useful chemical descriptor to discriminate liver injury-inducing drugs.
    Shimizu Y; Sasaki T; Takeshita JI; Watanabe M; Shizu R; Hosaka T; Yoshinari K
    PLoS One; 2021; 16(6):e0253855. PubMed ID: 34170966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes and Predictors of Mortality in Patients With Drug-Induced Liver Injury at a Tertiary Hospital in South India: A Single-Centre Experience.
    Sunil Kumar N; Remalayam B; Thomas V; Ramachandran TM; Sunil Kumar K
    J Clin Exp Hepatol; 2021; 11(2):163-170. PubMed ID: 33746440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of SLCO1B1*5 on Flucloxacillin and Co-Amoxiclav-Related Liver Injury.
    Alshabeeb M; Alomar FA; Khan A
    Front Pharmacol; 2022; 13():882962. PubMed ID: 35754504
    [No Abstract]   [Full Text] [Related]  

  • 24. Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.
    Goda K; Takahashi T; Kobayashi A; Shoda T; Kuno H; Sugai S
    J Toxicol Sci; 2016; 41(5):605-15. PubMed ID: 27665770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria.
    Porceddu M; Buron N; Roussel C; Labbe G; Fromenty B; Borgne-Sanchez A
    Toxicol Sci; 2012 Oct; 129(2):332-45. PubMed ID: 22987451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and pathological features in 138 cases of drug-induced liver injury].
    Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for severe or fatal drug-induced liver injury from amoxicillin-clavulanic acid.
    Yazici C; Mutlu E; Bonkovsky HL; Russo MW
    Hepatol Res; 2015 Jun; 45(6):676-82. PubMed ID: 25163514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic in vitro Assays.
    Shah F; Leung L; Barton HA; Will Y; Rodrigues AD; Greene N; Aleo MD
    Toxicol Sci; 2015 Oct; 147(2):500-14. PubMed ID: 26206150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
    Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced liver injury: recent advances in diagnosis and risk assessment.
    Kullak-Ublick GA; Andrade RJ; Merz M; End P; Benesic A; Gerbes AL; Aithal GP
    Gut; 2017 Jun; 66(6):1154-1164. PubMed ID: 28341748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury.
    Medina-Caliz I; Robles-Diaz M; Garcia-Muñoz B; Stephens C; Ortega-Alonso A; Garcia-Cortes M; González-Jimenez A; Sanabria-Cabrera JA; Moreno I; Fernandez MC; Romero-Gomez M; Navarro JM; Barriocanal AM; Montane E; Hallal H; Blanco S; Soriano G; Roman EM; Gómez-Dominguez E; Castiella A; Zapata EM; Jimenez-Perez M; Moreno JM; Aldea-Perona A; Hernández-Guerra M; Prieto M; Zoubek ME; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2016 Sep; 65(3):532-42. PubMed ID: 27184533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury.
    Mikus M; Drobin K; Gry M; Bachmann J; Lindberg J; Yimer G; Aklillu E; Makonnen E; Aderaye G; Roach J; Fier I; Kampf C; Göpfert J; Perazzo H; Poynard T; Stephens C; Andrade RJ; Lucena MI; Arber N; Uhlén M; Watkins PB; Schwenk JM; Nilsson P; Schuppe-Koistinen I
    Liver Int; 2017 Jan; 37(1):132-140. PubMed ID: 27224670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High daily dose and being a substrate of cytochrome P450 enzymes are two important predictors of drug-induced liver injury.
    Yu K; Geng X; Chen M; Zhang J; Wang B; Ilic K; Tong W
    Drug Metab Dispos; 2014 Apr; 42(4):744-50. PubMed ID: 24464804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective Role of microRNA-31 in Acetaminophen-Induced Liver Injury: A Negative Regulator of c-Jun N-Terminal Kinase (JNK) Signaling Pathway.
    Zheng J; Zhou H; Yang T; Liu J; Qin T; Gu X; Wu J; Zhang Y; Wang H; Tang Y; Xue F; Mao Y; Xia Q
    Cell Mol Gastroenterol Hepatol; 2021; 12(5):1789-1807. PubMed ID: 34311140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial abnormalities--a link to idiosyncratic drug hepatotoxicity?
    Boelsterli UA; Lim PL
    Toxicol Appl Pharmacol; 2007 Apr; 220(1):92-107. PubMed ID: 17275868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Physicochemical Properties on Dose and Hepatotoxicity of Oral Drugs.
    Leeson PD
    Chem Res Toxicol; 2018 Jun; 31(6):494-505. PubMed ID: 29722540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a Battery of
    Rathman J; Yang C; Ribeiro JV; Mostrag A; Thakkar S; Tong W; Hobocienski B; Sacher O; Magdziarz T; Bienfait B
    Chem Res Toxicol; 2021 Feb; 34(2):601-615. PubMed ID: 33356149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
    Xu HM; Chen Y; Xu J; Zhou Q
    World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Characteristics of Patients with Drug-induced Liver Injury.
    Yang LX; Liu CY; Zhang LL; Lai LL; Fang M; Zhang C
    Chin Med J (Engl); 2017 Jan; 130(2):160-164. PubMed ID: 28091407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Network pharmacology, molecular docking technology integrated with pharmacodynamic study to reveal the potential targets of Schisandrol A in drug-induced liver injury by acetaminophen.
    Li X; Ge J; Li M; Deng S; Li J; Ma Y; Zhang J; Zheng Y; Ma L
    Bioorg Chem; 2022 Jan; 118():105476. PubMed ID: 34788696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.